Tuesday, February 7, 2023


Biotechnology News Magazine


Jubilant Therapeutics Announces Research Collaboration with The Wistar Institute

This collaboration with Jubilant Therapeutics will further advance our comprehensive research efforts to find therapeutics to diminish cytokine storms and decrease COVID-19 symptom gravity.

AbCellera Granted U.S. Patent Covering its Trianni Mouse® Technology

AbCellera uses the transgenic animal technology to generate fully human monoclonal antibodies for its drug discovery programs with biotech and pharma partners.

LabMinds Successfully Receives Approval for Use in a GMP Certified Laboratory

LabMinds notes this approval follows a 12-month product development collaboration with a European based pharmaceutical leader.

Prosetta Biosciences Announces Novel Solution to COVID-19 Crisis

The compounds work in a new way: instead of interfering with the virus’s own functions, as do traditional antiviral drugs, this approach targets a newly appreciated structure within human cells that is hijacked and altered by viruses when they infect the cell, as part of their replication process.

StemVacs Cellular Immunotherapy – Positive Animal Data Reported States Therapeutics Solutions

"The current data, which conclusively demonstrates the induction of immunological memory to cancer, as well as the natural killer cell as a mechanism of action, will position us to provide the FDA responses to their questions from our submitted IND," said Dr. James Veltmeyer, Chief Medical Officer of the Company

Leading BioSciences Announces FDA Fast Track Designation Granted to LB1148 for the Treatment of Postoperative Gastrointestinal Dysfunction Associated with Pediatric Cardiovascular Surgery

Previously, LBS announced positive topline data from a Phase 2, randomized, double-blind, placebo-controlled, study that enrolled 120 adult open-heart surgery patients. This trial evaluated return of bowel function in adult patients undergoing open-heart surgery with cardiopulmonary bypass.